China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

China · Delayed Price · Currency is CNY

17.88

+0.06 (0.34%)

Apr 28, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Offset of Business Segment	-222.69M	-161.28M	-120.97M	-92.76M	-94.27M
Non-Infusion	8.46B	8.18B	8.12B	7.03B	6.50B
Non-Infusion Growth	3.42%	0.76%	15.50%	8.20%	8.13%
Infusion	2.76B	3.19B	3.31B	2.69B	2.71B
Infusion Growth	-13.44%	-3.62%	23.20%	-0.76%	4.78%
Total	11.00B	11.21B	11.31B	9.63B	9.11B
Total Growth	-1.88%	-0.87%	17.50%	5.64%	7.14%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	11.00B	11.21B	11.31B	9.63B	9.11B
China Growth	-1.88%	-0.87%	17.50%	5.64%	7.14%
Total	11.00B	11.21B	11.31B	9.63B	9.11B
Total Growth	-1.88%	-0.87%	17.50%	5.64%	7.14%

Source: S&P Global Market Intelligence.